RETURN TO
ARCHIVES MENU

|
 |
Technical
Committee on
Biotechnology Methods Discussion Archives
Methods for Detecting Biotechnology Events – DNA detection
Topic 2:
To decide on a quantitative method, what
types of samples should we evaluate?
Anne Bridges - 07:03am Jul 12, 2000 (#1
of 13)
I am getting the "message" that
we need to plan a quantitative PCR collaborative. If we focus on corn
samples, can we assume that other grains will respond similarly? Do we
need to evaluate processed product as well?
Jim Stave - 07:56am Jul 12, 2000 (#2 of
13)
Whether to use processed food fractions
depends on the objectives of the study. If the point is to determine if
some number of labs running the exact same procedure can come up with the
same answer, then it may not be necessary to have processed food
fractions. If the study is looking further to validate the use of a method
with certain food fractions then, just like any other method validation,
it is necessary to validate the method with the samples that the method is
intended to be used with. Heinz Schimmel has stated repeatedly that the
amount of processing of corn effects the result he gets from PCR. I can't
recall if he has determined if that is due to the quality or size of the
DNA, matrix, extractibility or what. I do recall that he believes it is
related to particle size.
Hamer Rob - 09:59am Jul 13, 2000 (#3 of
13)
What samples to measure? I suggest you
start at the end. Basically, GM-material can end up in a wide range of
foods, but there are some mainstreams. Analyse those and take out the
typical ones representing product categories or specific processing
methods (drying etc). Then, take a step back towards the source and select
some of the intermediary products. To keep things practical you should not
go beyond 10 samples. On the other hand, exploring typical sample
preparation related problems at an early stage (in my mind) is pure
wisdom.
Beth Curran - 02:48pm Jul 13, 2000 (#4
of 13)
I believe it would be wisest to restrict
ourselves to ingredients at the beginning, and separately evaluate
corn/soy/canola (if we decide canola should be included). Since lab
variation is such a problem, we should first show that we can get
consistent results on the less-processed materials, before we try finished
products. In my lab, we too have had trouble recovering DNA from highly
processed material. So I suggest we restrict the initial attempts to
ground whole grains, soy protein, corn grits, lecithin, etc. If the method
works, we can extend it (perhaps with some modifications) to more
processed materials for a second trial.
Frank Tenbarge - 04:00pm Jul 13, 2000
(#5 of 13)
I think it would be best to begin with a
PCR study using grain. This would provide us a good initial measure of the
consistency of results between labs. As you move to more processed
ingredients you have to deal with difficult problems related to the
presence of limited good quality DNA remaining in the sample after
processing and extraction procedures to isolate sufficient good quality
DNA. I think it is important to first establish the reliability of a PCR
procedure on a sample like grain before we move to more difficult samples.
Ralph Wilkinson - 04:22pm Jul 13, 2000
(#6 of 13)
The first samples should be whole grain,
ground ready for testing. The next step could be whole grain samples to
test sample prep procedures and any back to front contamination problems.
Later, ingredients such as unmodified corn starch, soy isolate etc. could
be tested. I think the first stage should be as simple as possible to
allow the "beginning" labs to catch up to the
"advanced" labs.
Andreas Wurz - 05:59am Jul 14, 2000 (#7
of 13)
In addition to opinions 4 to 6 I think the
GMO percentage of the samples should be from 0,1% to 5% for quantitative.
If we are not only talking about proficiency testing but method validation
there are other aspects to be defined or adressed: Number of replicates,
controls, specificity of the assay, nature of the calibration material to
be used ...
Michael Russell - 09:33am Jul 15, 2000
(#8 of 13)
In response to Ralph's posting: I trust he
is not suggesting that "advanced" labs that have technical
capability, or labs which are implementing a techncial advance, should not
offer those advanced services until/unless "beginning" labs can
offer the same services. I am pretty sure that clients want to have the
best available technology applied to their samples.
Beth Curran - 07:47am Jul 18, 2000 (#9
of 13)
Andreas, I would also very much like to see
samples at 0.01% GMO or even less for this first round. We don't have
concrete data on what levels will still give a positive result for the 35S
screen but we believe 0.01 still gives a strong positive in my lab, based
on the results of some spiked samples.
Jim Stave - 08:19am Jul 20, 2000 (#10
of 13)
I get the impression from this discussion
that each laboratory would run their own method. How is this different
from previous studies? If all the labs don't get the same result what
conclusion do you draw? Is the idea to validate the samples, the method(s),
or the laboratories? If you want to know about the variability of a method
between labs, every lab has to run the same procedure. If you want to
validate the detection limit of a method, you first determine during
method development what the detection limit is, and you use the study to
'validate' that the method can meet the claims. A collaborative study is
generally not used to develop the method, but to validate the performance
once it has been defined. Similarly, a collaborative study is not usually
used to determine if a method is appropriate for use with a particular
type of sample, rather it is an opportunity to evaluate the performance
against stated claims. During development the method would already have
been shown to perform with the particular sample type.
I believe the studies that have already
been completed have demonstrated that different labs using different
procedures will get different results. It would be useful to have data
regarding a specific method (like an official AACC or AOAC method) rather
than a generalization about a technology.
Beth Curran - 12:21pm Jul 28, 2000 (#11
of 13)
Jim, I've been assuming that we all would
be running the same procedure - or, at least, the same chemistry. I am
referring to situations similar to the PE TaqMan chemistry, which is
licensed to other companies for use with their detection systems (e.g.
Bio-Rad). I realize that this would mean that not all of the current
participants would be running the actual study, if they have committed
within their company to a chemistry which is different from the one we
choose for the collab.
Heinz Schimmel - 08:58am Aug 7, 2000
(#12 of 13)
Please read also my comment I made
concerning the former topic on criteria for quantitative methods vs
qualitative methods. I fully agree with the comment made by Jim Stave.
Processed samples are needed to fully validate a method. As stated in the
above mentioned comment we observed discrepancies between RR soybean
samples which contained the same amount of GMO but which were processed in
a different way. Since the GMO's end up in a large variety of products and
since the production processes of commodities can vary enourmously I would
recommend to carry out the validation studies using a limited number of
well defined materials and to focus on raw products and basic commodities.
This kind of study can be carried out by a limited number of pilot
laboratories. There are some guidelines how validations should be carried
out. These guidelines have been developed for chemical parameters where
one determines the absolute concentration of an analyte (identical with
the parameter to be determined) in a sample at the time it is analysed.
However the question does not fit to the GMO problem and therefore we
think that specific guidelines for the validation of GMO measurements need
to be developed. In the field of GMO measurements the parameter to be
determined (i.e. weight % GMO) is only measured indirectly via proteins or
DNA as the analyte. Therefore compared to the chemical validations one
needs to understand in addition what is the correlation between % GMO and
the analyte concentration and what happens to the analyte if the material
is processed or analysed. Possible deviations in the degree of DNA
degradation influence the quantitation even if normalised via a
housekeeping gene. The particle size distribution and the composition of
different seed parts, e.g. the oily embryo versus the endosperm, may have
an influence on the extraction efficiency and probably on the quantitative
result due to the fact that the genetic composition of the embryo and
endosperm in maize is different. Another question to be clarified for DNA
measurments (for protein it is obvious) is, whether the concentration of
DNA in non-GMO or GMO is constant or subject to variation which would have
a direct impact on the GMO quantitation via DNA. Therefore one needs to
run method validations in a much broader sense and not only with a limited
number of samples in order to get a realistic estimation of the
uncertainties related to the measurement process. If one decides to leave
the choice of the method to be used for GMO detection up to the
laboratories as long as they use a validated (the question is how far ?)
method then ring trials should be organised with laboratories using these
different methods in order to come up with a realistic estimate of the
uncertainties. Since there have been concerns that the scheme might become
too complicated especially for newcomers I would suggest I stepwise
approach. One could start with DNA preparations. However these would only
cover the final determination step and would be to some extend a help to
identify inhibitions. Purified DNA would not be suitable to determine
extraction efficiency. Next step could be to run ring trials on raw
materials and next processed materials. Following this approach I only see
the difficulty that you may discover problems at a very late stage because
a number of crucial points like unequal DNA degradation will only be
discovered with the last step. A last word concerning the quality of
materials to be used especially if one starts to talk about 0.01 %
materials. The materials need to be produced under fully controlled
conditions and to be of highest quality because the whole study will be
based on these materials. Making a 0.01 % material (e.g. maize or soybean
powder) goes far beyond simple grinding and mixing. It would be a major
challenge to get homogeneous material due to natural limitations like the
cell size and difficulties in obtaining small enough particles.
Klein Ileleji - 01:00pm Sep 26, 2000
(#13 of 13)
Heinz, I am not a biotechnologist and so
some of your terminologies are new to me. What do you mean by %GMO, DNA or
analyte in a sample? Do you mean the % GMO material in a sample? And if
processing degrades GMO or DNA, does it mean the final processed product
will be less contaminated by the GMO material, or still have the same
level of contamination? Thanks
RETURN TO TOP
© 2000 American Association of Cereal Chemists, Inc.
all rights reserved |